文献速递运动医学关节外科

三维打印聚己内酯支架复合间充质干细胞用于全半月板替代:兔模型12周和24周动物研究

3D-Printed Poly(ε-caprolactone) Scaffold Augmented With Mesenchymal Stem Cells for Total Meniscal Substitution: A 12- and 24-Week Animal Study in a Rabbit Model.
PubMed 文献 · Am J Sports Med · 2017-03-09

研究在72只新西兰白兔中比较细胞接种支架、无细胞支架、假手术和单纯全半月板切除四组,评估三维打印聚己内酯支架复合骨髓间充质干细胞的半月板再生与软骨保护效果。结果显示细胞接种组在24周时组织再生和力学性能优于无细胞组,且股骨和胫骨软骨退变显著更低。作者认为该支架有潜力作为半月板替代物,但临床应用前仍需进一步改进。

要点

  • 细胞接种支架组在24周时纤维软骨组织再生显著优于无细胞支架组。
  • 细胞接种组股骨和胫骨软骨退变显著低于无细胞组或半月板切除组。
  • 细胞接种组植入物拉伸和压缩性能显著高于无细胞组。

核心结论

  • 在聚己内酯支架上接种间充质干细胞可增加纤维软骨组织再生和机械强度,提供功能性替代以保护全半月板切除后的关节软骨。
  • 作者认为这种新型三维聚己内酯支架复合间充质干细胞有潜力作为半月板替代物,但临床应用前仍需进一步改进。

研究设计与样本

  • 研究为控制性实验室研究,共纳入72只新西兰白兔,分为细胞接种支架组、无细胞支架组、假手术组和单纯全半月板切除组。
  • 对三维打印聚己内酯半月板支架接种骨髓来源间充质干细胞,在术后12周和24周进行大体、组织学和扫描电镜分析,并评估植入物拉伸和压缩力学性能。

主要发现

  • 与无细胞组相比,细胞接种支架组大体外观显著更好,呈亮白色且表面光滑。
  • 在12周和24周时,细胞接种组和无细胞组植入物中均可见纤维软骨细胞及细胞外I、II、III型胶原和蛋白聚糖,而24周时细胞接种组结果显著更好。
  • 细胞接种组股骨和胫骨软骨退变显著低于无细胞组或半月板切除组。
  • 细胞接种组植入物的拉伸和压缩性能均显著高于无细胞组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出该方法在临床实践使用前仍需进一步改进。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total meniscectomy leads to knee osteoarthritis in the long term. The poly(ε-caprolactone) (PCL) scaffold is a promising material for meniscal tissue regeneration, but cell-free scaffolds result in relatively poor tissue regeneration and lead to joint degeneration. HYPOTHESIS: A novel, 3-dimensional (3D)-printed PCL scaffold augmented with mesenchymal stem cells (MSCs) would offer benefits in meniscal regeneration and cartilage protection. STUDY DESIGN: Controlled laboratory study. METHODS: PCL meniscal scaffolds were 3D printed and seeded with bone marrow-derived MSCs. Seventy-two New Zealand White rabbits were included and were divided into 4 groups: cell-seeded scaffold, cell-free scaffold, sham operation, and total meniscectomy alone. The regeneration of the implanted tissue and the degeneration of articular cartilage were assessed by gross and microscopic (histological and scanning electron microscope) analysis at 12 and 24 weeks postoperatively. The mechanical properties of implants were also evaluated (tensile and compressive testing). RESULTS: Compared with the cell-free group, the cell-seeded scaffold showed notably better gross appearance, with a shiny white color and a smooth surface. Fibrochondrocytes with extracellular collagen type I, II, and III and proteoglycans were found in both seeded and cell-free scaffold implants at 12 and 24 weeks, while the results were significantly better for the cell-seeded group at week 24. Furthermore, the cell-seeded group presented notably lower cartilage degeneration in both femur and tibia compared with the cell-free or meniscectomy group. Both the tensile and compressive properties of the implants in the cell-seeded group were significantly increased compared with those of the cell-free group. CONCLUSION: Seeding MSCs in the PCL scaffold increased its fibrocartilaginous tissue regeneration and mechanical strength, providing a functional replacement to protect articular cartilage from damage after total meniscectomy. CLINICAL RELEVANCE: The study suggests the potential of the novel 3D PCL scaffold augmented with MSCs as an alternative meniscal substitution, although this approach requires further improvement before being used in clinical practice.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Zhang ZZ, Wang SJ, Zhang JY, et al. 3D-Printed Poly(ε-caprolactone) Scaffold Augmented With Mesenchymal Stem Cells for Total Meniscal Substitution: A 12- and 24-Week Animal Study in a Rabbit Model. Am J Sports Med. 2017. PMID: 28278383. doi:10.1177/0363546517691513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。